The drug developer received
The uniform rental company raised its earnings forecast for the year.
The video game retailer's fourth-quarter earnings and revenue fell short of
The developer of biomaterials for wound care challenged a negative regulatory decision from the
The cloud-based software company beat analysts' fourth-quarter earnings forecasts.
The biopharmaceutical company is joining the S&P MidCap 400.
The cancer treatment developer said a potential lung cancer therapy met a key research goal.
Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
, source